Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
6.66
-0.40 (-5.67%)
At close: Oct 28, 2025, 4:00 PM EDT
6.66
0.00 (0.02%)
After-hours: Oct 28, 2025, 7:58 PM EDT
Organon & Co. Stock Forecast
Stock Price Forecast
The 3 analysts that cover Organon & Co. stock have a consensus rating of "Buy" and an average price target of $17.33, which forecasts a 160.21% increase in the stock price over the next year. The lowest target is $10 and the highest is $24.
Price Target: $17.33 (+160.21%)
Analyst Consensus: Buy
* Price targets were last updated on May 15, 2025.
Analyst Ratings
The average analyst rating for Organon & Co. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $24 → $18 | Buy | Maintains | $24 → $18 | +170.27% | May 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $10 | Hold | Maintains | $15 → $10 | +50.15% | May 5, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +125.23% | Apr 9, 2025 |
| Barclays | Barclays | Buy Maintains $26 → $24 | Buy | Maintains | $26 → $24 | +260.36% | Feb 14, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | +140.24% | Feb 14, 2025 |
Financial Forecast
Revenue This Year
6.35B
from 6.40B
Decreased by -0.80%
Revenue Next Year
6.39B
from 6.35B
Increased by 0.65%
EPS This Year
3.89
from 3.33
Increased by 16.73%
EPS Next Year
4.08
from 3.89
Increased by 4.99%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.6B | 6.7B | |||
| Avg | 6.4B | 6.4B | |||
| Low | 6.1B | 6.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.7% | 5.7% | |||
| Avg | -0.8% | 0.6% | |||
| Low | -4.2% | -4.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.11 | 4.47 | |||
| Avg | 3.89 | 4.08 | |||
| Low | 3.62 | 3.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.3% | 15.1% | |||
| Avg | 16.7% | 5.0% | |||
| Low | 8.6% | -6.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.